Cargando…

Practice effects in a longitudinal, multi-center Alzheimer’s disease prevention clinical trial

BACKGROUND: Practice effects are a known threat to reliability and validity in clinical trials. Few studies have investigated the potential influence of practice on repeated screening measures in longitudinal clinical trials with a focus on dementia prevention. The current study investigates whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abner, Erin L, Dennis, Brandon C, Mathews, Melissa J, Mendiondo, Marta S, Caban-Holt, Allison, Kryscio, Richard J, Schmitt, Frederick A, Crowley, John J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543284/ https://www.ncbi.nlm.nih.gov/pubmed/23171483 http://dx.doi.org/10.1186/1745-6215-13-217

Ejemplares similares

Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data
por: Abner, Erin L., et al.
Publicado: (2012)

Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI
por: Ding, Xiuhua, et al.
Publicado: (2019)

Feasibility of dual‐task gait to estimate Alzheimer's related cognitive decline in Down syndrome
por: Van Pelt, Kathryn L., et al.
Publicado: (2020)

Disease-related microglia heterogeneity in the hippocampus of Alzheimer’s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging
por: Bachstetter, Adam D., et al.
Publicado: (2015)

Alzheimer’s Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States
por: Jiang, Yang, et al.
Publicado: (2016)

Factors Associated with Unmet Needs among African-American Dementia Care Providers
por: Desin, PJ, et al.
Publicado: (2016)

Memory-Related Frontal Brainwaves Predict Transition to Mild Cognitive Impairment in Healthy Older Individuals Five Years Before Diagnosis
por: Jiang, Yang, et al.
Publicado: (2021)

A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging
por: Li, Juan, et al.
Publicado: (2017)

Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease
por: McBride, Joseph C., et al.
Publicado: (2014)

A neuropathologic feature of brain aging: multi-lumen vascular profiles
por: Ighodaro, Eseosa T., et al.
Publicado: (2023)

Brain structure changes over time in normal and mildly impaired aged persons
por: Smith, Charles D, et al.
Publicado: (2020)

Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease
por: Smith, Charles D., et al.
Publicado: (2016)

Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production
por: Lovell, Mark A., et al.
Publicado: (2015)

The African American United Memory and Aging Project: AD Knowledge and Family History as It Relates to Cognition
por: Gamaldo, Alyssa, et al.
Publicado: (2021)

A New Normal? Continued Impact of COVID19 on Alzheimer’s Clinical Trials Research
por: Rhodus, Elizabeth, et al.
Publicado: (2021)

Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease
por: Poulakis, Konstantinos, et al.
Publicado: (2022)

Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression
por: Andersen, Anders H., et al.
Publicado: (2015)

Assessing the Role of Trust in Public Health Agencies and COVID-19 Vaccination Status Among a Community Sample of African Americans in North Carolina
por: Lloyd, Shawnta L., et al.
Publicado: (2023)

(1)H-MRS metabolites in adults with Down syndrome: Effects of dementia
por: Lin, A.-L., et al.
Publicado: (2016)

Faster Cognitive and Functional Decline in Dysexecutive versus Amnestic Alzheimer's Subgroups: A Longitudinal Analysis of the National Alzheimer's Coordinating Center (NACC) Database
por: Mez, Jesse, et al.
Publicado: (2013)

Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial
por: Goodman, Phyllis J., et al.
Publicado: (2016)

Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer’s Disease Mouse Model
por: Hartz, Anika M. S., et al.
Publicado: (2018)

Sex-specific composite scales for longitudinal studies of incipient Alzheimer’s disease
por: Banks, Sarah J., et al.
Publicado: (2019)

Predictive Biomarkers of Gastroesophageal Reflux Disease and Barrett’s Esophagus in World Trade Center Exposed Firefighters: a 15 Year Longitudinal Study
por: Haider, Syed H., et al.
Publicado: (2018)

Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging
por: Abner, Erin L., et al.
Publicado: (2016)

INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol
por: Moga, Daniela C., et al.
Publicado: (2019)

Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
por: Wildsmith, Kristin R, et al.
Publicado: (2014)

Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study
por: Smith, Noah I., et al.
Publicado: (2023)

Redefining the Use of Digital Communities: AD Knowledge in an Online Educated Cohort of Midlife and Older Blacks
por: Brown-Hughes, Travonia, et al.
Publicado: (2021)

Longitudinal changes in microstructural white matter metrics in Alzheimer's disease
por: Mayo, Chantel D., et al.
Publicado: (2016)

Tissue engineering of the gastrointestinal tract: the historic path to translation
por: Collier, Claudia A., et al.
Publicado: (2022)

A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer’s Disease (REMEMBER)
por: Niemantsverdriet, Ellis, et al.
Publicado: (2018)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

An objective assessment of the variability in number of drops per bottle of glaucoma medication
por: Moore, Daniel B., et al.
Publicado: (2017)

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2023)

Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer’s Prevention
por: Mueller, Kimberly D., et al.
Publicado: (2020)

Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer’s Coordinating Center Uniform Data Set Study
por: Salazar, Christian R., et al.
Publicado: (2022)

1422. A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections
por: Ghali, Amer El, et al.
Publicado: (2022)

Limited predictive value of illness perceptions for short-term poor recovery in musculoskeletal pain. A multi-center longitudinal study
por: de Raaij, E. J., et al.
Publicado: (2021)

Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?
por: Head, Elizabeth, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_smg3dhfdt65374bdp01jsdp850